Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Bioactive Compounds

Items 7881-7890 of 13616

Page
per page
  1. WM-2474
    A8780 WM-2474
    Summary: Inactive analogue of WM-8014, used as control compound
      insoluble in EtOH; insoluble in H2O; ≥128.8 mg/mL
  2. AZD1390
    B8328 AZD1390
     1 Citation
    Summary: An effective, highly selective, brain-penetrable ATM inhibitor
      insoluble in H2O; ≥19.6 mg/mL
  3. Interleukin II (60-70)
    A1030 Interleukin II (60-70)
    Summary: Cytokine,regulating WBC
      insoluble in EtOH; ≥11.34 mg/mL
  4. BLU-554
    B8391 BLU-554
    Summary: A highly selective oral FGFR4 inhibitor for the treatment of hepatocellular carcinoma
      ≥50.4 mg/mL
  5. MS023
    B6183 MS023
     1 Citation
    Summary: type I PRMTs inhibitor
      ≥28.7 mg/mL
  6. Guvacoline (hydrobromide)
    C3017 Guvacoline (hydrobromide)
    Summary: full agonist of atrial and ileal muscarinic receptors
      ≤1 mg/mL
  7. (S)-SLV 319
    C3568 (S)-SLV 319
    Summary: CB1 receptor antagonist
      ≤30 mg/mL
  8. IWP-2-V2
    C3625 IWP-2-V2
    Summary: Wnt production inhibitor
      ≤2 mg/mL
  9. Bafilomycin C1
    C4729 Bafilomycin C1
    Summary: vacuolar H+-ATPases (V-ATPases) inhibitor
      Soluble in ethanol;Soluble in methanol;Soluble in DMSO;Soluble in dimethyl formamide
  10. Darglitazone
    C4758 Darglitazone
    Summary: PPARγ agonist with antidiabetic actions
      ≤5 mg/mL

Items 7881-7890 of 13616

Page
per page